We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
326
Fortinet
FTNT
$118B
$4.78M 0.05%
173,975
-8,980
-5% -$225K
FRC
327
DELISTED
First Republic Bank
FRC
$4.75M 0.05%
44,845
+1,407
+3% +$144K
GGG icon
328
Graco
GGG
$13.4B
$4.75M 0.05%
98,934
+3,201
+3% +$151K
CARR icon
329
Carrier Global
CARR
$52B
$4.73M 0.05%
+212,940
New +$3.96M
TSN icon
330
Tyson Foods
TSN
$19.6B
$4.6M 0.05%
76,973
+886
+1% +$53.7K
NWE icon
331
NorthWestern Energy
NWE
$4.34B
$4.57M 0.05%
83,785
+1,713
+2% +$99.2K
AKAM icon
332
Akamai
AKAM
$17.6B
$4.54M 0.05%
42,440
+786
+2% +$79K
GNRC icon
333
Generac Holdings
GNRC
$13.1B
$4.54M 0.05%
37,222
-24,373
-40% -$2.57M
ARWR icon
334
Arrowhead Research
ARWR
$12.3B
$4.52M 0.05%
104,622
+4,688
+5% +$165K
RSG icon
335
Republic Services
RSG
$65.6B
$4.51M 0.05%
54,945
+651
+1% +$52.5K
SLAB icon
336
Silicon Laboratories
SLAB
$7.22B
$4.51M 0.05%
44,946
+1,848
+4% +$173K
AEE icon
337
Ameren
AEE
$30.1B
$4.51M 0.05%
64,029
+612
+1% +$44.4K
MMS icon
338
Maximus
MMS
$2.85B
$4.5M 0.05%
63,937
+702
+1% +$47.2K
CPRT icon
339
Copart
CPRT
$26.8B
$4.5M 0.05%
216,136
+5,228
+2% +$105K
CTXS
340
DELISTED
Citrix Systems Inc
CTXS
$4.49M 0.05%
30,350
+703
+2% +$101K
CAG icon
341
Conagra Brands
CAG
$7.16B
$4.48M 0.05%
127,388
+1,947
+2% +$64.9K
TREX icon
342
Trex
TREX
$5.05B
$4.47M 0.05%
68,712
-47,618
-41% -$2.54M
LEN icon
343
Lennar Class A
LEN
$20.5B
$4.43M 0.05%
74,192
-331
-0.4% -$16.9K
TFX icon
344
Teleflex
TFX
$6.03B
$4.42M 0.05%
12,142
+208
+2% +$71.9K
LYB icon
345
LyondellBasell Industries
LYB
$20.3B
$4.42M 0.05%
67,202
+1,028
+2% +$61.2K
TTEK icon
346
Tetra Tech
TTEK
$9.09B
$4.41M 0.05%
278,530
+6,750
+2% +$103K
FCX icon
347
Freeport-McMoran
FCX
$96.9B
$4.39M 0.05%
379,744
+5,753
+2% +$52.7K
WY icon
348
Weyerhaeuser
WY
$17.8B
$4.38M 0.05%
195,159
+3,089
+2% +$62.5K
CMS icon
349
CMS Energy
CMS
$22B
$4.37M 0.05%
74,857
+1,694
+2% +$98.1K
WST icon
350
West Pharmaceutical
WST
$24.8B
$4.37M 0.05%
19,250
-23,222
-55% -$4.56M

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.